Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Multiple core targets” is a **collective, non-specific designation** used in systems biology, network pharmacology, and multi-omics research to describe a set of molecular entities (often genes or proteins) that occupy central roles (hubs) in molecular interaction, signaling, or regulatory networks implicated in disease or therapeutic response[2][3][4][6][8]. The concept typically arises in the context of drug discovery from analyses such as protein-protein interaction networks, pathway enrichment studies, or machine learning-based target prioritization. These "core targets" are not a single, discrete molecule or receptor, but a set of molecules hypothesized to be especially relevant for modulating complex biological processes or disease phenotypes. The actual targets included under this term vary by disease area, research methodology, and experimental dataset, and must be specified individually to yield actionable or structured pharmacological information. This entry is **not suitable** for structuring as a specific receptor, enzyme, or drug target and should be replaced by the explicit listing of the individual targets (e.g., TNF, IL6, EGFR, MAPK1, etc.) if known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple core targets.